Literature DB >> 8960086

The economic burden of Alzheimer's disease in Israel.

Z Rothstein1, I Prohovnik, M Davidson, M S Beeri, S Noy.   

Abstract

Owing to expected increases in the number of persons at risk for developing Alzheimer's disease and the expected decrease in the number of potential caregivers, the economic burden on society and families is expected to rise. Given changes in demographics and labor force participation, it is likely that the burden will be transferred from informal to formal paid services. Understanding the burden and cost of caring for this large population of patients is essential in order to make rational decisions with regard to allocating resources and providing quality care.

Entities:  

Mesh:

Year:  1996        PMID: 8960086

Source DB:  PubMed          Journal:  Isr J Med Sci        ISSN: 0021-2180


  2 in total

Review 1.  Clinical and economic factors in the treatment of behavioural and psychological symptoms of dementia.

Authors:  M E Hemels; K L Lanctôt; M Iskedjian; T R Einarson
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

2.  Alzheimer-Compound Identification Based on Data Fusion and forgeNet_SVM.

Authors:  Bin Yang; Wenzheng Bao; Shichai Hong
Journal:  Front Aging Neurosci       Date:  2022-07-25       Impact factor: 5.702

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.